Autopsy report · NCT03026088

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Limited beta-blocker naive participants among newly diagnosed heart failure participants, which led barrier to the recruitments.”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 1 year 9 months before it stopped.
20 participants enrolled.
Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: Merck KGaA, Darmstadt, Germany
Sponsor type: Industry
Conditions: Heart Failure
Interventions: Bisoprolol
Participants: 20
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.